2020 Global Lyme Disease Diagnostics Market: US, Europe, Japan--Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies
The report presents a detailed analysis of the Lyme disease diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Lyme disease definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:
- Hospitals
- Commercial/Private Labs
-Physician Offices
- Public Health Labs
In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Lyme disease tests.
Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.
List of Tables
Major Companies Developing or Marketing Lyme Disease Tests
France
Lyme Disease Test Volume and Diagnostics Sales Forecast
By Market Segment
France
Lyme Disease Testing Market Diagnostics Sales
By Major Supplier
Germany
Lyme Disease Test Volume and Diagnostics Sales Forecast
By Market Segment
Italy
Lyme Disease Test Volume and Diagnostics Sales Forecast
By Market Segment
Japan
Lyme Disease Test Volume and Diagnostics Sales Forecast
By Market Segment
Spain
Lyme Disease Test Volume and Diagnostics Sales Forecast
By Market Segment
Spain
Lyme Disease Testing Market Diagnostics Sales
By Major Supplier
U.K.
Lyme Disease Test Volume and Diagnostics Sales Forecast
By Market Segment
U.S.A.
Lyme Disease Test Volume and Diagnostics Sales Forecast
By Market Segment
U.S.A.
Lyme Disease Testing Market Diagnostics Sales
By Major Supplier
I. Introduction
II. Worldwide Test Overview,
Technologies and Instrumentation
A. Background, Diagnostic Tests, Vaccines and Drugs
B. Instrumentation Review: Operating Characteristics,
Features and Selling Princes of Leading Infectious Disease
Automated and Semi-automated Analyzers
C. Emerging Infectious Disease Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Others
D. Personal Testing
III. Country Analyses: Sales and Volume Forecasts
IV. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
V. Design Criteria for Decentralized Testing Products
VI. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
VII. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VIII. Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- GSK Biologicals
- Hologic
- Leica Biosystems
- Lonza
- Ortho-Clinical Diagnostics
- PerkinElmer
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens Healthineers
- Takara Bio
- Thermo Fisher
- Wako
United States Toys Market – Growth, Demand, Trends, Opportunity, Forecasts (2020 – 2027)
The United States toys market is set to surpass US$ 56 Billion by 2027.Report Scope: The Market Size of the United States Toys Market with Six Years Forecast The United
USD 900 View ReportUnited States Self-Monitoring Blood Glucose (SMBG) Market Analysis 2015 – 2020 and Industry Forecast 2021 – 2027
The United States market for the self-monitoring blood glucose is anticipated to cross US$ 4.6 billion by the year-end of 2027.
USD 2500 View ReportGlobal Lyme disease Market Outlook
The global marketplace for Lyme disease diagnostic is projected to grow due to the accelerating number of patients affected by Lyme diseases. Lyme disease is a communicable disease caused by
USD 3950 View ReportGlobal Lyme Disease Diagnostics Market Research Report 2021-2025
In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Lyme Disease Diagnostics Report by Material, Application, and Geography Global
USD 3200 View ReportFill The Form For Sample Request